Last reviewed · How we verify
NCT05097235: T3PredCohSt
Type 3 Predictive Observational Study for Sensory Profiles in Central Sensitization in Low Back Pain Population.
trial in Sensory Profiles, Nociplastic Pain, Low Back Pain in 114 participants. Completed in 31 May 2023.
31 May 2023
Quick facts
| Lead sponsor | Vrije Universiteit Brussel |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 114 |
| Start date | 1 May 2022 |
| Primary completion | 31 May 2023 |
| Estimated completion | 31 May 2023 |
| Sites | 1 location across Netherlands |
Conditions studied
- Sensory Profiles, Nociplastic Pain, Low Back Pain — all drugs for Sensory Profiles, Nociplastic Pain, Low Back Pain →
Sponsor
Vrije Universiteit Brussel — full company profile →
Who can join
Adults 18 to 60, any sex, with Sensory Profiles, Nociplastic Pain, Low Back Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study conducts prognostic research to develop, validate, and evaluate the predictive role of sensory profiles in the development of sensory profiles over time. Therefore, a type 3 prognostic model research will be conducted in the low back pain population.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Sensory Profiles Predict Symptoms of Central Sensitization in Low Back Pain: A Predictive Model Research Study.
Gräper PJ, Scafoglieri A, Clark JR, Hallegraeff JM. · · 2024 · cited 4× · PMID 39200819 · DOI 10.3390/jcm13164677 -
Sex-Specific Sensory Profiles Discriminate Between Sensitization at Twelve Weeks in Patients with Acute Low Back Pain: A Retrospective Study.
Gräper PJ, Scafoglieri A, Hallegraeff JM. · · 2025 · PMID 39860628 · DOI 10.3390/jcm14020621
Verify or expand the search:
- PubMed search for NCT05097235
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Vrije Universiteit Brussel trials
Trials by the same sponsor.
- NCT07460778 — Development of Serious Games for Rehabilitation: a Delphi Study · NA · recruiting
- NCT07359521 — Implementation and Evaluation of a Complex Intervention to Reduce Avoidable Transitions Between Nursing Home and Hospita · NA · not yet recruiting
- NCT07356336 — Cognitive Model for Behavioral Interventions as a Non-pharmacological Intervention for Behavioral and Psychological Symp · NA · recruiting
- NCT07212829 — The Added Value of Transcranial Direct Current Stimulation (tDCS) During Exercise for People With Chronic Widespread Pai · NA · not yet recruiting
- NCT07294131 — Targeting Muscle Strength Loss Due to Hospitalization in Older Adults by Blood-flow Restriction Combined With an Electro · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05097235 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Vrije Universiteit Brussel
- Last refreshed: 13 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05097235.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing